LS 216
Alternative Names: PDT research programme - Light Sciences; Photodynamic therapy research programme - Light Sciences; Research programme photodynamic therapy - Light SciencesLatest Information Update: 24 Mar 2005
At a glance
- Originator Roswell Park Cancer Institute
- Developer Light Sciences Corporation; Roswell Park Cancer Institute
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 24 Mar 2005 Discontinued - Phase-I for Cancer in USA (unspecified route)
- 24 Feb 2005 No development reported - Phase-I for Cancer in USA (unspecified route)
- 12 Jun 2002 Phase-I clinical trials in Cancer in USA (unspecified route)